Insulin pump maker Insulet has acquired Automated Glucose Control LLC's assets related to its automated insulin delivery technology for $25 million.
The companies have had an established partnership since 2016. The Calif.-based company's founders consulted with Insulet during the development of its Omnipod 5 Automated Insulin Delivery system.
"AGC played a critical role in facilitating the...
Tasso received FDA 510(k) clearance for its patch-like blood collection device, the Tasso+.
The device includes a lancet, which adheres to the arm, that connects to a test tube for collection. After users rub their arm or use a heat pack and sanitize the test site, they press a button on the front of the device to begin drawing capillary blood. Then the tube can be removed and sent to a lab for...
Tasso, maker of a device for at-home blood collection, has raised $100 million in Series B financing.
The round was led by RA Capital Management, with participation from the D.E. Shaw group, Senvest, InCube, SVB Innovation Fund, Foresite Capital, Hambrecht Ducera Growth Ventures, J2V, Cedars-Sinai and Merck GHIF.
The latest financing builds upon a $17 million Series A from last year and a $6.1...
Tasso, a Seattle-based startup working on bringing blood testing to the home via a wearable patch-like device, has raised $6.1 million in Series A funding. Vertical Venture Partners led the round, with additional participation from TechStars and Cedars Sinai. This is the first major VC round for the company, but it has previously been supported by $13.1 million in grant funding from DARPA, NIH,...
Cedars-Sinai Medical Center's third accelerator class held its demo day last week as the 10 companies announced a slew of pilots, deployments, and other deals. Nine out of the 10 companies has a pilot or commercial deal with Cedars-Sinai itself, but a number of companies also have deals with other hospitals, payers, or pharma companies. One, Tasso, has a $6 million grant contract with the...
Cedars-Sinai Medical Center in Los Angeles has launched the third class of its accelerator, which the hospital runs in partnership with TechStars.
Startups in the Cedars-Sinai Tech Stars accelerator receive a $20,000 investment and a $100,000 convertible bridge grant in exchange for a 6 percent equity stake. But the main draw is the opportunity to work with the health system, through guaranteed...
